bioRxiv preprint doi: https://doi.org/10.1101/2020.10.09.331728; this version posted October 10, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. TITLE: Accelerated erythrocyte senescence causes dose-limiting anemia of antimalarial enolase inhibitors SHORT TITLE: Antiglycolytic antimalarials induce RBC senescence SCIENTIFIC CATEGORY: Red cells Andrew J. Jezewski1,2,6, Yu-Hsi Lin3, Julie A. Reisz5, Rachel Culp-Hill5, Yasaman Barekatain3, Victoria C. Yan3, Angelo D’Alessandro5, Florian L. Muller3,4, Audrey R. Odom John1,2,7,* 1Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 2Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 3Department of Cancer Systems Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 4Department of Neuro-Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 5Department of Biochemistry and Molecular Genetics, University of Colorado Denver – Anschutz Medical Campus, Aurora, CO 6Department of Pediatrics, University of Iowa, Iowa City, IA (current institution) 7Department of Pediatrics, Children’s Hospital of Philadelphia, and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (current institution) * Corresponding author and Lead Contact: Audrey R. Odom John Email:
[email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.10.09.331728; this version posted October 10, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.